title: Alphavirus-Based Vaccines.
abstract: Alphavirus-based vectors have been engineered from Semliki Forest virus, Sindbis virus, and Venezuelan equine encephalitis virus and applied for vaccine development. Immunization in preclinical animal models has been conducted with naked RNA replicons, recombinant viral particles and layered DNA-RNA vectors. Most commonly, the targets for the immunization have been viral surface proteins and tumor antigens, which have elicited strong immune responses and even provided protection against challenges with lethal doses of virus and tumor cells, respectively. As alphaviruses also cause epidemics, vaccines have been developed against Chikungunya virus. Despite the success in several animal smodels only a few clinical trials have been conducted in humans, so far.
authors.affiliation: PanTherapeutics, Rue des Remparts 4, Lutry, 1095, Switzerland. lundstromkenneth@gmail.com.
authors.forename: Kenneth
authors.initials: K
authors.lastname: Lundstrom
mesh_terms: D000524:Alphavirus / Q000235:genetics*; D000818:Animals; D016466:CHO Cells; D019556:COS Cells; D002460:Cell Line; D002522:Chlorocebus aethiops; D006224:Cricetinae; D003412:Cricetulus; D057809:HEK293 Cells; D006801:Humans; D051379:Mice; D010957:Plasmids / Q000235:genetics; D014611:Vaccination; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology*
chemical_list: D014765:Viral Vaccines
keywords: Alphaviruses; Cancer vaccines; Immunization; Neutralizing antibodies; Protection; Viral vaccines